Recruiting at 1 site No phase Diabetes Mellitus, Type 2

Clinical trial for Diabetes Mellitus, Type 2

Official title Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance

ClinicalTrials.gov ID: NCT05165706

What this study is testing

What it's testing
The study aims to find out how losing weight changes the body's cells and improves how they respond to insulin.
Who it's for
The study is looking for adults who have obesity, pre-diabetes, or early signs of liver fat.
What's involved
Participants will follow a specific diet plan and give blood, fat tissue, and stool samples at three different times. They will also have scans to measure fat in their belly and liver.
Time commitment
The study lasts 12 weeks and requires visits at the start, after 4 weeks, and at the end.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 35 to 65. Healthy volunteers may be eligible.

You may be able to join if

  • Age 35-65
  • BMI 25-35 kg/m2
  • Stable body weight
  • Nondiabetic

You likely can't join if

  • Patients with;
  • diabetes
  • major organ disease
  • history of liposuction or bariatric surgery
  • active eating or psychiatric disorder
  • pregnancy or lactation, heavy alcohol use
See the full eligibility criteria
Who can join
  • Age 35-65
  • BMI 25-35 kg/m2
  • Stable body weight
  • Nondiabetic
What rules you out
  • Patients with;
  • diabetes
  • major organ disease
  • history of liposuction or bariatric surgery
  • active eating or psychiatric disorder
  • pregnancy or lactation, heavy alcohol use
  • recent change in weight (over the past 12 weeks)
  • use of weight loss medication, statins, or oral steroids Clinical screening exclusions;
  • hematocrit \< 33%
  • fasting glucose \>/= 126 mg/dL
  • blood pressure \>160/100 mmHg

The study team makes the final eligibility decision.

Where it is enrolling

  • Stanford, California, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 35 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Stanford, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.